MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has

See also
Status	Clinical Trial	Phase
Completed	`NCT01349348` - Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites	Phase 3
Active, not recruiting	`NCT04682847` - Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers
Recruiting	`NCT05904470` - A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV	Phase 2
Completed	`NCT02138253` - A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV	Phase 2
Recruiting	`NCT02652351` - Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis	Phase 1
Completed	`NCT00794482` - Multi-national Cirrhosis Study to Characterise the Association Between the Pharmacokinetics of NRL972 and Disease Severity.	Phase 3
Completed	`NCT00856713` - Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers	Phase 1
Completed	`NCT02163512` - Effect of Beta-adrenergic Blockers on Cardiac Function, Systemic and Splanchnic Haemodynamic and Kidney Function in Cirrhotic Patiets With Refractory Ascites
Completed	`NCT00857480` - Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin	Phase 1
Completed	`NCT00006164` - Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment	Phase 3
Completed	`NCT03486912` - A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis	Phase 2
Completed	`NCT00698464` - Pharmacokinetics and Safety of Single Subcutaneous Pasireotide (SOM230) in Subjects With Varying Degrees of Hepatic Function	Phase 1
Completed	`NCT02778425` - The Treatment of Hepatocirrhosis and Portal Hypertension	N/A
Completed	`NCT03445208` - A Study of Experimental Medication BMS-986036 Given to Healthy Participants	Phase 1
Completed	`NCT03420768` - A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C	Phase 2
Completed	`NCT03804593` - HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
Completed	`NCT02230670` - A Study of IDN-6556 in Subjects With Liver Cirrhosis	Phase 2
Completed	`NCT02230683` - A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension	Phase 2
Completed	`NCT01135628` - Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy	N/A
Completed	`NCT00856869` - Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers	Phase 1/Phase 2

NCT number	NCT03712280
Study type	Interventional
Source	Mallinckrodt
Contact
Status	Completed
Phase	Phase 2
Start date	December 1, 2018
Completion date	July 14, 2020

MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms